Potential relevance of type I interferon-related biomarkers for the management of polygenic autoimmune rheumatic diseases with childhood onset

Clin Rheumatol. 2023 Jul;42(7):1733-1736. doi: 10.1007/s10067-023-06645-1. Epub 2023 May 29.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Autoimmune Diseases* / drug therapy
  • Autoimmune Diseases* / genetics
  • Biomarkers
  • Child
  • Humans
  • Interferon Type I* / therapeutic use
  • Rheumatic Diseases* / drug therapy
  • Rheumatic Diseases* / genetics

Substances

  • Interferon Type I
  • Biomarkers